» Articles » PMID: 17056891

Intracellular Lipid Within Metastatic Hepatocellular Carcinoma of the Adrenal Gland: a Potential Diagnostic Pitfall of Chemical Shift Imaging of the Adrenal Gland

Overview
Specialties Oncology
Radiology
Date 2006 Oct 24
PMID 17056891
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Non-contrast spectral CT vs chemical-shift MRI in discriminating lipid-poor adrenal lesions.

Nagayama Y, Uchimura R, Maruyama N, Taguchi N, Yoshida R, Harai R Eur Radiol. 2024; 35(1):370-380.

PMID: 38985184 DOI: 10.1007/s00330-024-10929-8.


Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.

Nagayama Y, Hayashi H, Taguchi N, Yoshida R, Harai R, Kidoh M Abdom Radiol (NY). 2024; 49(5):1626-1637.

PMID: 38456897 DOI: 10.1007/s00261-024-04228-5.


Radiomics approach based on biphasic CT images well differentiate "early stage" of adrenal metastases from lipid-poor adenomas: A STARD compliant article.

Cao L, Xu W Medicine (Baltimore). 2022; 101(38):e30856.

PMID: 36197274 PMC: 9509040. DOI: 10.1097/MD.0000000000030856.


[Adrenal imaging: anatomy and pathology (literature review)].

Korb T, Chernina V, Blokhin I, Aleshina O, Vorontsov A, Morozov S Probl Endokrinol (Mosk). 2021; 67(3):26-36.

PMID: 34297499 PMC: 9753838. DOI: 10.14341/probl12752.


Comparison of MRI features in lipid-rich and lipid-poor adrenal adenomas using subjective and quantitative analysis.

Tu W, Gerson R, Abreu-Gomez J, Udare A, McPhedran R, Schieda N Abdom Radiol (NY). 2021; 46(10):4864-4872.

PMID: 34120206 DOI: 10.1007/s00261-021-03161-1.